TY - JOUR
T1 - The Signaling Pathways of Erythropoietin and Interferon-γ Differ in Preventing the Apoptosis of Mature Erythroid Progenitor Cells
AU - Paiboonsukwong, Kittiphong
AU - Choi, Ilseung
AU - Matsushima, Takamitsu
AU - Abe, Yasunobu
AU - Nishimura, Junji
AU - Winichagoon, Pranee
AU - Fucharoen, Suthat
AU - Nawata, Hajime
AU - Muta, Koichiro
N1 - Funding Information:
This research was conducted in part at the Kyushu University Station for Collaborative Research and was partially supported by the National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand, by a Kyushu University P&P grant, and by the Ministry of University Affairs and the Faculty of Graduate Studies, Mahidol University, during the 2001-2002 academic year. K.P. is in the PhD/MD scholar program of Mahidol University. S.F. is a senior research scholar of the Thailand Research Fund. We express our deep appreciation to S. Aoki, S. Isewaki, and M. Hirakawa for excellent technical assistance. We are indebted to Dr. S. B. Krantz (Department of Medicine-Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA) for a critical reading of the manuscript.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003/12
Y1 - 2003/12
N2 - Interferon (IFN)-γ is a survival factor for mature erythroid progenitor cells. To elucidate related survival mechanisms, we compared the role of phosphatidylinositol 3-kinase (PI3-kinase) in the survival signals of IFN-γ and erythropoietin (EPO). Human erythroid colony-forming cells (ECFCs) purified from peripheral blood were used, and Ly294002 was used as a PI3-kinase inhibitor. Treating ECFCs with a high concentration of Ly294002 (50 μmol/L) in the presence of EPO and/or IFN-γ reduced cell viability by inducing apoptosis. However, treating cells with a lower concentration of Ly294002 (10 μmol/L) did not affect the antiapoptotic function of IFN-γ and abolished the antiapoptotic effect of EPO. Adding IFN-γ or EPO induced Bcl-x expression in ECFCs, as determined by Western blotting, and expression was suppressed in the presence of Ly294002. We also examined the phosphorylation of the protein kinase Akt, the downstream target of PI3-kinase. EPO stimulation significantly increased the level of Akt phosphorylation, but IFN-γ did not. These results suggest that IFN-γ plays a role in preventing the apoptosis of erythroid progenitor cells by affecting Bcl-x expression, thereby reducing the disruption of the mitochondrial transmembrane potential via PI3-kinase pathways that are related to but distinct from the EPO pathway.
AB - Interferon (IFN)-γ is a survival factor for mature erythroid progenitor cells. To elucidate related survival mechanisms, we compared the role of phosphatidylinositol 3-kinase (PI3-kinase) in the survival signals of IFN-γ and erythropoietin (EPO). Human erythroid colony-forming cells (ECFCs) purified from peripheral blood were used, and Ly294002 was used as a PI3-kinase inhibitor. Treating ECFCs with a high concentration of Ly294002 (50 μmol/L) in the presence of EPO and/or IFN-γ reduced cell viability by inducing apoptosis. However, treating cells with a lower concentration of Ly294002 (10 μmol/L) did not affect the antiapoptotic function of IFN-γ and abolished the antiapoptotic effect of EPO. Adding IFN-γ or EPO induced Bcl-x expression in ECFCs, as determined by Western blotting, and expression was suppressed in the presence of Ly294002. We also examined the phosphorylation of the protein kinase Akt, the downstream target of PI3-kinase. EPO stimulation significantly increased the level of Akt phosphorylation, but IFN-γ did not. These results suggest that IFN-γ plays a role in preventing the apoptosis of erythroid progenitor cells by affecting Bcl-x expression, thereby reducing the disruption of the mitochondrial transmembrane potential via PI3-kinase pathways that are related to but distinct from the EPO pathway.
UR - http://www.scopus.com/inward/record.url?scp=0346218119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0346218119&partnerID=8YFLogxK
U2 - 10.1007/BF02983814
DO - 10.1007/BF02983814
M3 - Article
C2 - 14704034
AN - SCOPUS:0346218119
SN - 0925-5710
VL - 78
SP - 421
EP - 428
JO - International journal of hematology
JF - International journal of hematology
IS - 5
ER -